Merck & Company, Inc. · NYSE:MRK
DeLuca Richard R. sold 45,320 Merck & Company, Inc. shares (Form 4)
Traded Aug 10 to Aug 12, 2026 · Filed Aug 12, 2026
From Aug 10 to Aug 12, 2026, DeLuca Richard R. (EVP&Pres, Merck Animal Heallth) sold 45,320 Merck & Company, Inc. shares at an average US$131.12 for US$5.94M, leaving 110,167 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 45,320 shares
- Price
- US$131.12 average (US$130.43 to US$132.35)
- Value
- US$5.94M
- Holding after
- 110,167 shares
- Trading plan
- No
- Role
- EVP&Pres, Merck Animal Heallth
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Sale | 20,784 | US$130.43 | 134,703 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 7,410 | US$131.33 | 127,293 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 5,427 | US$132.35 | 121,866 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 11,099 | US$131.61 | 110,767 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 600 | US$132.04 | 110,167 | Direct |
Source
Related
- Merck & Company, Inc.
- DeLuca Richard R.
- Merck & Company, Inc. shareholders
- Form 4 · DeLuca Richard R. · Aug 10, 2026
- Form 4 · DeLuca Richard R. · May 1, 2026
- Form 4 · Guindo Chirfi · Aug 13, 2026
- Form 4 · Zachary Jennifer · Aug 13, 2026
- Form 4 · Guindo Chirfi · Aug 7, 2026
- Form 4 · Maraldo David R. · Aug 7, 2026
- Form 4 · Williams David Michael · Aug 7, 2026